Anti-aging peptide research spans several distinct biological mechanisms — from telomere maintenance and mitochondrial function to tissue repair and immune regulation. Unlike cosmetic anti-aging (addressed in our skin peptides guide), this guide covers peptides studied for systemic aging processes at the cellular and molecular level.
The field is heterogeneous: some peptides on this list have decades of research history, while others are relatively new discoveries from mitochondrial biology. Evidence quality varies significantly, from Russian clinical data (epithalon) to preclinical rodent studies (MOTS-c). We rank by the combination of mechanistic plausibility, available evidence, and breadth of anti-aging applications studied.
Important: No peptide has been proven to reverse aging in humans. Anti-aging claims should be evaluated critically, and any peptide use should be discussed with a healthcare provider. This guide is for educational purposes and does not constitute medical advice or endorse any specific anti-aging protocol.
Epithalon
Best for: Telomerase activation targeting telomere-length maintenance
Epithalon (Epitalon) is a synthetic tetrapeptide developed by Dr. Vladimir Khavinson that activates telomerase, the enzyme responsible for maintaining telomere length — a key biomarker of cellular aging. Russian clinical studies reported increased telomerase activity and potential lifespan extension in animal models. It has the most direct mechanism targeting a core hallmark of aging (telomere attrition), though most evidence comes from Russian literature that has not been independently replicated in Western trials.
GHK-Cu
Best for: Multi-pathway anti-aging with gene expression modulation and human study support
GHK-Cu is a copper-binding tripeptide that declines with age (plasma levels drop from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60). Research has identified it as a gene expression modulator affecting over 4,000 genes, many related to tissue repair, antioxidant defense, and anti-inflammatory signaling. It has published human data in dermatology and is the only anti-aging peptide with a robust consumer product market.
BPC-157
Best for: Systemic tissue maintenance and regeneration as an anti-aging adjunct
While primarily known for healing, BPC-157's systemic regenerative effects — including cytoprotection, angiogenesis, and modulation of growth factor receptors — have implications for age-related tissue deterioration. Its ability to protect and repair gastrointestinal mucosa, tendons, and neural tissue makes it relevant to maintaining functional health during aging, even though it does not target aging hallmarks directly.
MOTS-c
Best for: Mitochondrial function and metabolic resilience (emerging hallmark-of-aging target)
MOTS-c is a mitochondrial-derived peptide that regulates metabolic homeostasis and has shown benefits in insulin sensitivity, exercise capacity, and resistance to metabolic stress in preclinical studies. It targets mitochondrial dysfunction — one of the nine hallmarks of aging — and represents a newer frontier in aging research. Evidence is primarily from mouse models and cell studies.
Thymosin Alpha-1
Best for: Immune system restoration addressing age-related thymic involution
Thymosin alpha-1 (Zadaxin) is an immune-modulating peptide approved in over 35 countries for hepatitis B/C and as an immune adjuvant. Thymic involution (the shrinking of the thymus gland) is a central feature of immune aging, and thymosin alpha-1 partially restores T-cell function. Its relevance to anti-aging is through immunosenescence — the age-related decline of immune function that underlies increased infection risk, cancer susceptibility, and reduced vaccine response in the elderly.
Selank
Best for: Neuroprotective and stress-resilience support for cognitive aging
Selank is a synthetic peptide approved in Russia as an anxiolytic that modulates GABA, serotonin, and dopamine systems. Its relevance to anti-aging lies in its neuroprotective and immunomodulatory properties, including BDNF modulation. Chronic stress and neuroinflammation are accelerators of biological aging, and selank's ability to modulate these pathways positions it as a supportive peptide for cognitive aging and stress resilience.
Frequently asked questions
No peptide has been proven to reverse aging in humans. Some peptides target specific hallmarks of aging — telomere maintenance (epithalon), mitochondrial function (MOTS-c), immune restoration (thymosin alpha-1) — and may slow certain age-related processes based on preclinical data. Longevity science is advancing rapidly, but claims of aging reversal should be evaluated with appropriate skepticism.
A commonly discussed longevity stack combines epithalon (telomere maintenance), GHK-Cu (tissue repair and gene expression), and BPC-157 (systemic regeneration) to address multiple aging pathways simultaneously. No clinical trials have studied these combinations for anti-aging purposes. Any multi-peptide protocol should be discussed with a healthcare provider.
GHK-Cu levels decline naturally with age. Research shows it modulates over 4,000 human genes, many involved in tissue repair, antioxidant defense, collagen synthesis, and anti-inflammatory signaling. It can be applied topically for skin aging or used systemically. It is one of the few anti-aging peptides with published human data, primarily in dermatological applications.
Epithalon has shown lifespan extension in rodent and cell culture studies through telomerase activation. Russian clinical data reports telomere elongation in human subjects. However, these results have not been independently replicated in Western clinical trials with rigorous methodology. Telomere-length maintenance is a plausible anti-aging mechanism, but proving lifespan extension in humans requires decades of follow-up data that does not yet exist.
Long-term safety data is limited for most anti-aging peptides. Thymosin alpha-1 has the most established safety profile, with approval in 35+ countries and extensive clinical use. GHK-Cu is well-tolerated topically with decades of cosmetic use. Epithalon, MOTS-c, and others lack long-term human safety data. Telomerase activation specifically raises theoretical concerns about cancer risk, though this has not been observed in available studies.